Guoping Zhao is a molecular microbiologist and has been working on microbial molecular physiology and metabolic regulation since his graduation from Fudan University, Shanghai China in 1982. Currently, he is the Director of Laboratory of Synthetic Biology, at the Institute of Plant Physiology and Ecology (IPPE), Shanghai Institutes for Biological Sciences (SIBS), Chinese Academy of Sciences (CAS).
Guoping Zhao was elected as a member of the CAS in 2005 and elected as the President of the Chinese Society for Microbiology in 2006. He was appointed as the Director of Shanghai Research Center of Biotechnology (SRCB), CAS, from 1997 to 1999 and the Vice-President of SIBS from 1999 to 2002, where he began to work for the Human Genome Project of the CAS (1998-2001). Since 2002, he has been the Executive Director of the Chinese National Human Genome Center at Shanghai and Director of the National Engineering Center for BioChip at Shanghai. Meanwhile, he focused his research activities on genomics and systems biology of microorganisms, including the genomic study of Leptospira interrogans, the functional genomic study of Xanthomonas campestris, the evolution genomic study of SARS coronavirus, and the comparative genomic study of Mycobacterium tuberculosis.
Guoping Zhao obtained his Ph.D. degree of Biochemistry from Purdue University, Indiana, USA in 1990 and returned to China in 1992 as the founding production manager of Shanghai Promega Biological Products, Ltd, a subsidiary joint venture of SRCB, CAS. He was promoted to full Professor in 1995 after rejoining the Shanghai Institute of Plant Physiology (SIPP), CAS.